| abstract |
The present invention relates to a nucleic acid molecule, a genetic construct, siRNA molecules and a composition comprising the nucleic acid molecule and / or the genetic construct and / or the siRNA molecules and useful for inhibiting the expression of endothelial adhesion molecules. The invention also relates to a device coated with or containing the above molecule, composition or construct. The present invention further relates to a corresponding use of the nucleic acid molecule, the genetic construct or the siRNA molecules and a method for inhibiting the expression of adhesion molecules and a vascular graft, lung transplant, lung graft treatment method and a method for the treatment of the open heart in the context of cardioplegia , |